节点文献
淋病奈瑟菌的耐药性及产β-内酰胺酶研究
Study on drug resistance to antimicrobial agents and β-lactamase producing of Neisseria gonorrhoeae
【摘要】 目的 了解淋病奈瑟菌的耐药性及β -内酰胺酶的产生情况。方法 对门诊 1998~ 2 0 0 1年分离的 60 2株淋病奈瑟菌进行 14种抗菌药物的耐药性分析 ,同时检测β -内酰胺酶。结果 药敏试验结果显示 :头孢噻肟 (Cefo taxime,CTX)和原始霉素 (Pristinomycin ,PRI)的耐药率分别为 4 65 %和 4 98% ,而甲氧苄氨嘧啶 (Trimethoprim ,TMP)的耐药率为 94 5 2 %。 60 2株淋病奈瑟菌中产β-内酰胺酶淋病奈瑟菌 (PPNG)占 3 8 87% ,抗四环素淋病奈瑟菌 (TRNG)占 16 44 %。结论 头孢噻肟和原始霉素应作为本地区目前临床治疗淋病奈瑟菌感染的首选药物
【Abstract】 Objective To survey drug resistance and β-lactamase producing.Methods β-lactamase producing Ngonorrhoeae(PPNG) and the drug resistance of 14 antibiotics to 602 strains from 1998 to 2001 were determined respectively.Results The results showed the susceptibility of the isolates to cefotaxime and pristinomycin was highest(9535%,9502% respectively) and trimethoprim was lowest(316%).The drug resistance to trimethoprim was highest(9452%)and cefotaxime and pristinomycin was lowest(465%,498% respectively).3887% of 602 isolates NGonorrhoeae were PPNG,and 1644% were TRNG.Conclusion Cefotaxime and pristinomycin are drugs of first choice in treatment of Neisseria gonorrhoeae infection in this area.
【Key words】 Neisseria gonorrhoeae Drug resistance β-lactamase producing neisseria gonorrhoeae;
- 【文献出处】 中国全科医学 ,Chinese General Practice , 编辑部邮箱 ,2003年03期
- 【分类号】R446.5
- 【被引频次】1
- 【下载频次】23